Mangiferin Inhibits Renal Urate Reabsorption by Modulating Urate Transporters in Experimental Hyperuricemia
- 1 January 2015
- journal article
- Published by Pharmaceutical Society of Japan in Biological & Pharmaceutical Bulletin
- Vol. 38 (10), 1591-1598
- https://doi.org/10.1248/bpb.b15-00402
Abstract
Mangiferin, a natural glucosyl xanthone from the leaves of Mangifera indica L., was previously shown to exert potent hypouricemic effects associated with inhibition of the activity of xanthine dehydrogenase/oxidase. The present study aimed to evaluate its uricosuric effect and possible molecular mechanisms underlying the renal urate transporters responsible for urate reabsorption in vivo. Mangiferin (1.5–24.0 mg/kg) was administered intragastrically to hyperuricemic mice and rats induced by the intraperitoneal injection of uric acid and potassium oxonate, respectively. The uricosuric effect was evaluated by determining the serum and urinary urate levels as well as fractional excretion of uric acid (FEUA). The mRNA and protein levels of renal urate-anion transporter 1 (URAT1), organic anion transporter 10 (OAT10), glucose transporter 9 (GLUT9), and PDZ domain-containing protein (PDZK1) were analyzed. The administration of mangiferin significantly decreased the serum urate levels in hyperuricemic mice in a dose- and time-dependent manner. In hyperuricemic rats, mangiferin also reduced the serum urate levels and increased the urinary urate levels and FEUA. These results indicate that mangiferin has uricosuric effects. Further examination showed that mangiferin markedly inhibited the mRNA and protein expression of renal URAT1, OAT10, and GLUT9 in hyperuricemic rats, but did not interfere with PDZK1 expression. Taken together, these findings suggest that mangiferin promotes urate excretion by the kidney, which may be related to the inhibition of urate reabsorption via downregulation of renal urate transporters.Keywords
This publication has 26 references indexed in Scilit:
- Uric acid as a danger signal in gout and its comorbiditiesNature Reviews Rheumatology, 2012
- Association Between Serum Uric Acid Level and Metabolic SyndromeJournal of Preventive Medicine & Public Health, 2012
- Extra-Renal Elimination of Uric Acid via Intestinal Efflux Transporter BCRP/ABCG2PLOS ONE, 2012
- Homozygous SLC2A9 Mutations Cause Severe Renal HypouricemiaJournal of the American Society of Nephrology, 2010
- Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathyProceedings of the National Academy of Sciences of the United States of America, 2009
- Identification of a urate transporter, ABCG2, with a common functional polymorphism causing goutProceedings of the National Academy of Sciences of the United States of America, 2009
- Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid ConcentrationsPLoS Genetics, 2009
- Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in HumansOnline Journal of Public Health Informatics, 2008
- Identification of a New Urate and High Affinity Nicotinate Transporter, hOAT10 (SLC22A13)Online Journal of Public Health Informatics, 2008
- Gout, diuretics and the kidneyAnnals Of The Rheumatic Diseases, 2006